CVS Health Corporation (CVS) reportedly saw its stock price decrease by 10.5% in trading on Tuesday, following the announcement of lowered guidance for the year and the appointment of a new CEO. The company now anticipates adjusted earnings per share (EPS) to be between $7.15 and $7.35 for the year, down from its previous projection of $7.45 to $7.65.
